Objective Hypertension (HTN), obesity and low cardiorespiratory fitness (CRF) are associated with an increased risk for a cardiovascular event. Enrolling overweight/obese individuals with HTN, the current study aimed to estimate cardiovascular risk (CVR) and vascular age (VA) profiles analyzing potential sex differences, determine whether VA is higher than chronological age, and whether CVR is associated with a low level of CRF.
Introduction
Cardiovascular disease (CVD) is the leading cause of early morbidity and hospitalization in the world [1] . According to the WHO 17.5 million people died from CVD in 2012, representing 31% of all deaths, of which 7.4 and 6.7 million were due to coronary heart disease and cardiovascular (CV) events, respectively [2] . Furthermore, a large number of individuals have a heightened risk for CVD because they have two or more associated risk factors [1, 3, 4] .
Several attempts have been made to determine cardiovascular risk (CVR) factors associated with a cardiac event.
Guidelines indicate that age, sex, diabetes, smoking, cholesterol and hypertension (HTN) have a causal relationship with CV events and premature death [1, 3, 5] . High blood pressure (BP), often referred to as HTN, is the most common CVR factor that leads to heart failure, stroke, angina and premature death if not detected early and treated adequately [6] . Additionally, population-based research suggests that obesity is directly related to HTN [7] . An appreciation of the clinical significance of obesityrelated HTN has since grown substantially over time. As such, obesity is now recognized as a major cause of HTN (≥75% of all cases), and the combination of both is well known to increase CVR [7] . Additionally, CVR factors, associated with the development of CVD, are similar in both sexes [8] . However, with the same risk factors, CVR is 2-5 times more common in men than in women; that is, women have a lower predicted 10-year risk [9] . It has previously been suggested that this discrepancy may be due to the protective action of estrogens [8] or because substantial disparities exist in the prevention, recognition, management and clinical outcomes of CVD in women [10] . A CVR score can be used to determine CVD using the Pooled Cohort Equations and the Framingham Heart Study, which are tools commonly used to define the 10-year risk for developing CVD [9] . An additional tool for evaluating the overall CVR is vascular age (VA). This is a quite novel concept derived from Framingham CVR tables, which indicates the biological age of an individual's arteries (i.e. the age of the vascular system of a person with different CVR factors) [1, 11] . This process is accelerated with the presence of additional CVR factors and is associated with changes in the mechanical and structural properties of the vascular wall, which leads to poor endothelial health and loss of arterial elasticity [1, 7] .
The relationship between poor lifestyle and increased CVR is well documented. As such, there is a persistent need to discuss cardiometabolic lifestyle factors with all patients, in order to reduce CVD and control the CVR factors. CVR factors can be classified as modifiable and nonmodifiable. Nonmodifiable risk factors are (but not limited to) age, sex and family history. Modifiable CVR factors are cardiometabolic lifestyle factors and can be altered during the cause of one's life; these include but are not limited to smoking, alcohol, diet and importantly physical activity [12] . Higher levels of physical activity can improve the CVR in diseased or at-risk patients. Cardiorespiratory fitness (CRF) can be used to quantify these positive effects as it is negatively associated with a reduction in CV morbidity and mortality [12] .
Currently, there is no known research that measures CVR and VA and its association with CRF in primary hypertensive and overweight/obese adults. Considering the importance of CVR factors and the limited scientific literature, the aims of the study were (a) to estimate CVR and VA profiles of overweight/obese patients with HTN, analyzing potential sex differences, (b) to determine whether VA is higher than chronological age (CA) and (c) to determine whether CVR is associated with a low level of CRF.
Methods

Study design
Baseline data from the EXERDIET-HTA randomized controlled experimental trial were taken for the purpose of this study [13] . The design, selection criteria and procedures for the EXERDIET-HTA study have been previously detailed [13] . The study protocol was approved by the Ethics Committee of the University of the Basque Country (UPV/EHU, CEISH/279/2014) and the Ethics Committee of Clinical Investigation of Araba University Hospital (2015-030), and all participants provided written informed consent before any data collection.
Participants
Non-Hispanic White participants (n = 209) with primary HTN [ ≥ 140 systolic blood pressure (SBP) and ≥ 90 diastolic BP] [4] , who were classified as being overweight (BMI ≥ 25) or obese (BMI ≥ 30) [14] were recruited from the cardiology services and local media.
Cardiorespiratory fitness
Cardiorespiratory fitness was determined using a cardiopulmonary exercise test to assess VO 2peak . Briefly, the test was performed on an electronically braked Lode Excalibur Sport Cycle Ergometer (Groningen, The Netherlands). The testing protocol was started at 40 W (70 rpm) with gradual increments of 10 W every minute until exhaustion with continuous ECG monitoring. Expired gas analysis was determined using a commercially available metabolic cart (Ergo CardMedi-soft S.S, Sorinnes, Belgium; Ref. USM001 V1.0), which was calibrated before each test with a standard gas of known concentration and volume. Breath-by-breath data were measured continuously during exercise before being averaged over each 60 s period. Blood pressure was measured every 2 min throughout the test. At the end of each stage the rate of perceived exertion (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) was recorded (Borg Scale). Peak oxygen uptake was defined as the highest oxygen uptake value attained toward the end of the test. Achievement of VO 2peak was assumed with the presence of two or more of the following criteria: (a) volitional fatigue (>18 on Borg Scale); (b) peak respiratory exchange ratio (VCO 2 /VO 2 ) of at least 1.1; (c) achieving more than 85% of age predicted maximum heart rate; and (d) failure of VO 2 and/or heart rate to increase with further increases in work rate [13] .
The distributions of VO 2peak were divided into tertiles for each sex: the lowest tertile (low-CRF group), VO 2peak ≤ 21 in men and VO 2peak ≤ 16 in women; the intermediate tertile (medium-CRF group); 21.1 < VO 2peak ≤ 26 in men and 16.1 < VO 2peak ≤ 21 in women; and the highest tertile (high-CRF group), VO 2peak more than 26 in men and VO 2peak more than 21 ml·kg/min in women.
Measurement of cardiovascular disease risk factors
Established CVR factors used in the present study to determine the CVR and VA of participants were defined as follows:
Blood pressure Ambulatory BP monitoring was conducted over a 24 h period using an oscillometric ambulatory BP monitoring 6100 recorder (Welch Allyn, New York, New York, USA) to evaluate SBP (as used to determine CVR) [9] . The device was used in line with the recommendations set by the ESH/ESC guidelines. As such, BP was measured at 30-min intervals during the awake time and at 60-min intervals during periods of sleep. Data were only used if at least 75% of the awake time and sleep periods were successfully recorded [13] .
Blood sampling
Fasting venous blood (12.5 ml) was obtained from each participant. Diabetes mellitus (DM) was defined as a fasting glucose of at least 126 mg/dl. Additionally, measurements of glucose and lipid profile [total cholesterol, Cardiovascular risk and hypertension Gorostegi-Anduaga et al. 155
high-density lipoprotein cholesterol (HDL-C), and lowdensity lipoprotein cholesterol (LDL-C)] were assayed.
Self-report
Age and cigarette smoking status were assessed by selfreport. All medicines were ascertained from the participant's physician.
Cardiovascular risk
The Framingham Heart Study is a quantitative method used in primary care for assessment of general CVR profile. The absolute risk applies to the individual; a score of 10% means that there is a 10% chance of having a CV event within the next 10 years [9, 11] , under 6% is considered low risk, between 6 and 20% is considered medium risk, and a score of at least 20% is considered high risk [11] . Recently, New Pooled Cohort Risk Equations have been developed from the Framingham Heart Study [9, 11] . The equation to estimate the 10-year risk of developing a first atherosclerotic CVD event was developed from sex-specific and race-specific proportional-hazard models that included the covariates of age, treated or untreated high SBP level, total cholesterol and HDL-C concentrations, current smoking status, and history of DM. For the equation, the values for age, lipids, and SBP were log transformed. Interactions between age and lipids or age and SBP used the natural log of each variable. Calculation of the 10-year risk estimate for hard atherosclerotic CVD is described as a series of steps [9] .
Vascular age
The Framingham method was used to determine the VA of all participants [11] . The VA indicates the biological age of the individual's vascular system, as the age a person would be with the same calculated CVR but whose risk factors were all within normal ranges. The sex-specific risk factors considered were age, HDL-C, total cholesterol, SBP, DM and smoking status. Each variable received a weighted score; the sum of the score for each variable was then translated to the risk for a CV event in 10 years and the VA [11] .
Statistical analysis
Descriptive statistics were calculated for all variables. Data are expressed as mean SD. All variables were deemed normally distributed using a Kolmogorov-Smirnov test, apart from age, total cholesterol, HDL-C, CVR, and VA, which had a skewed distribution and were therefore log transformed before any analysis.
A two sample t-test was used to determine whether there was a significant sex difference for the variables: age, BMI, SBP, total cholesterol, HDL-C, antihypertensive medication, cigarette smoking, and DM. Analysis of covariance was used to examine the dependant variables (age, BMI, SBP, total cholesterol, HDL-C, antihypertensive medication, cigarette smoking, DM, CVR, and VA) of the participants classified by CRF level (low, medium, and high). A Bonferroni test was used to determine the level of significance when a significant main effect was found. Statistical significance was set at P value less than 0.05. The statistical analyses were performed with SPSS, version 22.0 (IBM SPSS Statistics for Windows, IBM Corp., Armonk, New York).
Results
The characteristics of CVR factors classified by sex are presented in Table 1 . The mean SD age of participants was 54.0 8.1 years with 67.5 and 32.5% being men and women, respectively. All participants were classified as obese (BMI > 30 kg/m 2 ) in accordance with AHA/ACC/ TOS guidelines for the Management of Overweight and Obesity in Adults [14] . Although 87.1% of all participants were taking antihypertensive medication, the mean SBP suggested that all participants irrespective of sex were prehypertensive. However, there was a trend to suggest that women had a lower SBP compared with men [mean difference = 1.6; 95% confidence interval (CI) = − 2.5-5.7 mmHg]. The mean total cholesterol was similar in men and women, with both sexes exceeding cutoff values set by the ESH/ESC guidelines [4] , but there was also a trend to suggest that women had lower total cholesterol than did men (mean difference = 3.3; 95% CI = − 30.6-37.3 mmHg). Moreover, HDL-C was significantly higher (P = 0.002) in women than in men (mean difference = 5.0, 95% CI = − 13.3-3.3 mg/dl), but both were inside the healthy cutoff values suggested by the ESH/ESC guidelines [4] . Smoking was present in 11.4% of the participants, and 4.5% of the sample was suffering from DM.
The absolute CVR was significantly different (P < 0.001) between sexes, with women having a lower CVR than did men (mean difference 5.8, 95% CI = − 3.8-7.7%, Table 1 ). Additionally, in accordance with the Framingham study and ACC/AHA Guidelines on the assessment of CVR [9, 11] , men were considered to be at medium risk, whereas women were considered low risk. As shown in Table 2 , there were no sex differences in VA (mean difference = 1.4, 95% CI = − 2.4-5.1 years). However, VA was significantly higher (P = 0.001) than CA (mean difference = 8.8, 95% CI = 7.2-10.3 years).
Characteristics of the participants separated into CRF groups are presented in Table 3 . Bonferroni analysis revealed that age was higher (P < 0.05, Δ = − 9.7%) in the low CRF group compared with that in the high CRF group. Moreover, BMI was higher in the low CRF group compared with that in the medium CRF group Bonferroni analysis revealed that no significant differences were observed in CVR (P = 0.907) and VA (P = 1.643), when values were separated into CRF groups (Table 3) . However, the low CRF group showed an upward trend in VA with higher values compared with those with medium CRF (mean difference = 0.5, 95% CI = − 4.1-5.0 years) or higher CRF (mean difference = 3.4, 95% CI = − 1.5-8.4 years).
Discussion
To our knowledge this is the first known study to estimate the CVR and VA in overweight/obese people with HTN and its association with CRF level using the recently developed Pooled Cohort Equations [9] and the original 2008 Framingham model. The main findings of this study were as follows: (a) CVR is significantly higher in men than in women despite them having the same CVR values and this is not affected by age; (b) predicted VA is significantly higher than CA in overweight/obese people with primary HTN with no sexrelated differences; and (c) CRF alone did not appear to significantly moderate CVD. These findings highlight the importance of being able to determine the CVR and VA of overweight/obese people with primary HTN. Considering the known increase in CVD in hypertensive patients and the relative ease of predicting 10-year CVR; defining CVR and VA in a hypertensive population would likely be a useful tool for clinicians.
Although the role of major CVR factors in the development of CVD and VA was similar in both sexes, Table 1 shows that CVR is 57% higher in men than in women (P = 0.001), with an estimated 10-year risk for hard atherosclerotic CVD event of 10% in men and 4.3% in women, which represents medium and low risk, respectively. As such, it is likely that men have a higher risk of suffering a CV event in the following 10 years. The difference in the HDL-C level could be one of the determinants of the sex-related difference in CVR profile in Values are mean SD or percentage. %Variance is the estimated variance explained by the mean effects within each group for the named variable. ANOVA, analysis of variance; DM, diabetes mellitus; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure. *Shows the significantly different (P < 0.05) among groups.
the present study, with women showing higher concentrations compared with men. It is well known that high concentrations of HDL-C prevent the development of atherosclerosis and CVD. In particular, the transport of reserve cholesterol and the inhibition of oxidized LDLinduced monocyte infiltration can avoid this development [15] . In addition, the Framingham Heart Study showed that HDL-C was the most powerful lipid predictor of CHD risk in both sexes older than 49 years. For every 1 mg/dl increment in HDL-C, there was an associated 2% decrease in the risk for CHD in men, and a 3% decrease in women [16] . Previous studies have shown that the increased CVR in men was hidden behind an almost-normal classic lipid profile, with total cholesterol, LDL-C, and TG being higher, and HDL-C concentrations significantly lower than those in women (premenopausal or postmenopausal status), with all values within the normal range [17] . In our study, both sexes presented hyperlipidemia values (total cholesterol > 190 mg/dl) and prehypertensive SBP values with slight, but concomitant variation (i.e. an upward trend in men compared with women), which has been shown to increase the risk for coronary heart disease and promote a poor cardiometabolic profile [17] . It seems that there is a cardioprotective effect of endogenous estrogens in premenopausal women, when compared with age-matched men, due to an enhanced HDL quality. However, in postmenopausal women there is a trend to present with a significantly increased BMI, BP, LDL-C, and total cholesterol, along with a reduction in absolute HDL-C concentration, with changes in the composition of HDL particles [17, 18] . In the present study, 51.5% of women were premenopausal. Therefore, it should take into account that in the current study: (a) both men and women had normal HDL-C values (>40 mg/dl for men and > 46 mg/dl for women) [4] , along with obesity, hypercholesterolemia, and primary HTN diagnostic; (b) almost half of the women were postmenopausal; and (c) the sex-specific risk prediction model used in the Pooled Cohort Equation always calculates a higher risk in men compared with women, despite them having the same CVR values and regardless of age [9] . As such, women could show an underestimated CVR profile with lessaggressive treatment strategies. Nowadays, a greater number of women die annually from CVD compared with men [19] . Thus, although sex-related differences are well documented in the prevalence of CVR factors, the clinical manifestation and incidence of CVD and the impact of risk factors on outcomes [20] in women are often underestimated because of the misperception that females are 'protected' against CVD [21] .
As expected, VA was significantly higher (P = 0.001) than CA (VA = 62 vs. CA =54 years) ( Table 2 ). As such, people with primary HTN and obesity are 'older' for their VA when compared with their CA. It is therefore likely that the health of the heart and blood vessels is more deteriorated than they should be in this population [11] . There is good evidence that CA is strongly and independently related to CVR, but this is not necessarily so for the VA. Repeated exposure to CVR factors across the lifespan leads to between-subject differences in VA and CA [22] . Previous research has shown that in apparently healthy and asymptomatic people, 72.45% of the individuals had a greater VA than CA, suggesting that this risk may be underestimated [23] . The current study suggests that key contributors of an increased VA in a hypertensive population are dyslipidemia, SBP, treatment for HTN, obesity and smoking (87.2% of them showing a greater VA than CA). Thus, VA seems to be a useful tool in communicating about risk to individuals, such as hypertensive and obese patients, who are at a greater risk for a CVD event and warrant early intervention of modifiable CVR factors (i.e. healthy eating, increasing physical activity, cessation of cigarette smoking and alcohol).
It is well recognized that physical activity is an important factor for reducing CVR and CVD [9, 12] . Previous research has suggested that people with sedentary behaviors are at a higher risk for all-cause mortality compared with those who do at least 150 min of moderate-intensity or 75 min of vigorous-intensity aerobic physical activity per week, as recommended by WHO [12] . In the current study it was found that CRF alone does not significantly moderate CVR, because of no differences among the three CRF groups (Table 3) . However, the mean difference and CI suggest that those who are in the low CRF group have meaningfully higher VA (although not significant) (Table 3) , which suggests that CVR may in part be moderated by CRF but in conjunction with other CVR factors such as BMI and age. Aging and inactivity are associated with a decrease in both CRF and morphological changes in all layers of the vascular tree, and these are accompanied by increased arterial stiffness and aortic pressure, leading to a higher VA [24] . Furthermore, in the present study BMI explained 22.5% and age 6% of the variance between the CRF groups. The current study reinforces the evidence linking obesity, age and CRF level with VA in a primary hypertensive population [7, 25] , suggesting that low CRF could potentially be used in conjunction with other CVR factors to help determine predisposal of CVD, but not as a factor in its own right. Previous studies have concluded that physical activity is associated with beneficial changes in circulating lipids and lipoproteins, body mass, BP and insulin sensitivity, having a significant reduction in CVR [12, 25] . In line with that, the last 2016 European Guidelines on CVD prevention in clinical practice highlight CRF as a factor that might influence the relationship between adiposity and clinical prognosis in the 'obesity paradox'. Thus, normal-weight individuals with a low CRF have a higher risk for mortality than fit individuals, regardless of their BMI [1, 26] .
Although our study has highlighted the importance of determining CVR factors in a hypertensive population, several limitations should be acknowledged. First, although our sample size was sufficient as an initial investigation into CVR and HTN, it would not be comparable to that of larger epidemiological studies, and future studies should consider large-scale investigations as well as determining the short-term and long-term effects of different interventions. Second, the current study had only 32.5% women, which does not represent an equal sex split. As this poses statistical issues, future studies, particularly those using interventions, should look to recruit equal numbers. Finally, although CRF did not sufficiently moderate CVR in the current study, the effects of physical activity in hypertensive patients with a broader range of VO 2peak should be further investigated in conjunction with other modifiable risk factors to determine the effectiveness of moderating CVR and VA. Additionally, future studies should look to determine whether VA and CVR can be used to more easily inform patients of their cardiovascular health than current methods.
Conclusion
Findings suggest that male non-Hispanic White overweight/obese individuals with diagnosed HTN have a higher risk of suffering a CV event in the following 10 years compared with women according to the greater CVR assessed using the Pooled Cohort Equations. However, CVR in women could be underestimated when both sexes present with the same CVR values and age. Those who are overweight/obese with HTN have an 'older' VA compared with their CA irrespective of sex. Finally, although CRF alone did not moderate CVR in the current study, further research into the effect of physical activity alongside additional modifiable CVR factors in HTN populations, particularly those who are the least active, is warranted. Predictions of CVR and VA estimation may represent a useful clinical tool for detecting patients at risk for a cardiac event, but estimation equations should be more focused on sex-related differences.
